Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

Abstract With the continuous in-depth study of the interaction mechanism between viruses and hosts, the virus has become a promising tool in cancer treatment. In fact, many oncolytic viruses with selectivity and effectiveness have been used in cancer therapy. Human enterovirus is one of the most con...

Full description

Bibliographic Details
Main Authors: Bopei Cui, Lifang Song, Qian Wang, Kelei Li, Qian He, Xing Wu, Fan Gao, Mingchen Liu, Chaoqiang An, Qiushuang Gao, Chaoying Hu, Xiaotian Hao, Fangyu Dong, Jiuyue Zhou, Dong Liu, Ziyang Song, Xujia Yan, Jialu Zhang, Yu Bai, Qunying Mao, Xiaoming Yang, Zhenglun Liang
Format: Article
Language:English
Published: Nature Publishing Group 2023-09-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-023-01603-4

Internet

https://doi.org/10.1038/s41392-023-01603-4

Similar Items